Skip to content
Home/Companies/HealthTech/Diagnoly

Diagnoly

HealthTech·France·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Diagnoly?

Diagnoly is a French HealthTech company, currently owned by Newfund Management since 2025 and XAnge.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
XAnge
Most recent investor
XAnge
XAnge 5 · 2025 · VC
2 ownership periods · full history below

Key facts

HQFrance
SectorHealthTech

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Newfund Management and XAnge since 2025.
Co-invest · 2 holders · 2025 · present
Newfund Management
Newfund ManagementActive
2025 · present(1yr) · Newfund HEKA · 2023 · VC
XAnge
XAngeActive
2025 · present(1yr) · XAnge 5 · 2025 · VC

More from XAnge 5

Other portfolio companies in the same fund.

getinside
Active
SaaSFrance· 2026
VSORA
Vsora
Active
Deep TechFrance· 2026
Ensweet
Ensweet
Active
HealthTechFrance· 2025
Knowunity
Active
EdTechGermany· 2025
Tomorro
Tomorro
Active
SaaSFrance· 2025
Iptego
Exited 2011
Cloud InfrastructureGermany· 2010
to Orvell Technologies

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Diagnoly?

Diagnoly is currently owned by Newfund Management and XAnge, through XAnge 5, since 2025.

When did Newfund Management and 1 other acquire Diagnoly?

Newfund Management and 1 other acquired Diagnoly in 2025.

Who has owned Diagnoly over time?

Diagnoly has been through 2 private-equity ownership periods: Newfund Management · via Newfund HEKA · since 2025; XAnge · via XAnge 5 · since 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue